1052091-65-2

Upstream product

• 162809-97-4 2'-O-(tert-butyldimethylsilyl)-10-deacetyl-7-O-triethylsilylpaclitaxel 
• 162664-57-5 2'-O-TBDMS-7-O-TES-9-α-OH-9-desoxo-10-epi-paclitaxel 
• 162664-54-2 2'-O-TBDMS-7-O-TES-9,10-diketo-paclitaxel 
• 162664-56-4 2'-O-TBDMS-7-O-TES-9,10-α,α-OH-9-desoxo-10-deacetylpaclitaxel 
• 162375-26-0 2'-O-(tert-butyldimethylsilyl)-10-deacetylpaclitaxel 
• 114655-02-6 2'-O-(tert-butyldimethylsilyl)paclitaxel 
• 33069-62-4 taxol 
• 2186-92-7 p-Anisaldehyde dimethyl acetal 
• 1051405-75-4 C₅₅H₅₉NO₁₅ 
• 1051405-72-1 C₄₇H₅₃NO₁₄ 
• 849213-03-2 2-O-TBDMS-9-α-OH-9-desoxo-10-epi-paclitaxel 
• 849213-13-4 iso-butyl sidechain acid 
• 1051405-78-7 C₃₉H₄₆O₁₂ 

Downstream Products

• 1051405-83-4 C₄₃H₆₁NO₁₅ 

Relevant academic research and scientific papers

BIOLOGICALLY ACTIVE TAXANE ANALOGS AND METHODS OF TREATMENT BY ORAL ADMINISTRATION

The present invention relates to a novel chemical compound of formula S-(I) for use in the treatment of cancer, to compositions containing said compound, methods of manufacture and combinations with other therapeutic agents.

TAXANE ANALOGS FOR THE TREATMENT OF BRAIN CANCER

Provided herein are compounds and methods for the treatment of brain cancer in a mammal, wherein the method comprises the administration to the mammal a compound that stabilizes tubulin dimers or microtubles at G2-M interface during mitosis but is not a s